Literature DB >> 6272291

Increased susceptibility to cytomegalovirus infection in beige mutant mice.

G R Shellam, J E Allan, J M Papadimitriou, G J Bancroft.   

Abstract

Mice homozygous for the beige gene (bg/bg) are a homologue of the Chédiak-Higashi syndrome of man and are known to be selectively defective in natural killer (NK) cells. We have compared the susceptibility of bg/bg and bg/+ C57BL/6J mice to infection with murine cytomegalovirus (MCMV). Beige mice are more susceptible to lethal infection and develop 33- to 43-fold higher virus titers in the liver, spleen, and kidney than do bg/+ mice after a sublethal infection, although virus replication is the same in vitro in cultured fibroblasts or epithelial cells from these mice. Inoculation with a sublethal dose of virus stimulates a NK cell response, although this is lower in bg/bg mice despite higher titers of interferon type 1 than in bg/+. A dose of MCMV that is lethal only to bg/bg augments cytotoxicity within 12 hr in bg/+ mice, whereas cytotoxicity in bg/bg remains very low. In bone marrow chimeras, recipients of bg/bg marrow were more susceptible to MCMV and had lower NK cell responses after virus inoculation than did recipients of marrow from bg/+ donors. The greater susceptibility of beige mice to the virus suggests that NK cells may contribute to resistance early in McMV infection.

Entities:  

Mesh:

Year:  1981        PMID: 6272291      PMCID: PMC320341          DOI: 10.1073/pnas.78.8.5104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.

Authors:  J C Roder; M L Lohmann-Matthes; W Domzig; H Wigzell
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

3.  The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

Review 4.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

5.  Giant granules of beige mice. A quantitative marker for granulocytes in bone marrow transplantation.

Authors:  E D Murphy; D E Harrison; J B Roths
Journal:  Transplantation       Date:  1973-05       Impact factor: 4.939

6.  Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.

Authors:  M K Selgrade; A Ahmed; K W Sell; M E Gershwin; A D Steinberg
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

7.  The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.

Authors:  J C Roder
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  Augmentation of cell-mediated cytotoxicity to a rat lymphoma. I. Stimulation of non-T-cell cytotoxicity in vivo by tumour cells.

Authors:  H J Dawkins; G R Shellam
Journal:  Int J Cancer       Date:  1979-08       Impact factor: 7.396

9.  Role of T lymphocytes in recovery from murine cytomegalovirus infection.

Authors:  S E Starr; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  A single genetic element in H-2K affects mouse T-cell antiviral function in poxvirus infection.

Authors:  U Kees; R V Blanden
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

View more
  65 in total

1.  Correlation between natural killer cell activation in the bone marrow and haemopoietic dysfunction following cytomegalovirus infection of mice.

Authors:  A E Gibbons; G R Shellam; P Price
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 3.  Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors.

Authors:  Michal Pyzik; Eve-Marie Gendron-Pontbriand; Nassima Fodil-Cornu; Silvia M Vidal
Journal:  Mamm Genome       Date:  2010-09-30       Impact factor: 2.957

4.  Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 5.  Natural killer cells in immunodefense against infective agents.

Authors:  Nicolas Zucchini; Karine Crozat; Thomas Baranek; Scott H Robbins; Marcus Altfeld; Marc Dalod
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

6.  Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance.

Authors:  Sofia A Oliveira; Se-Ho Park; Peter Lee; Albert Bendelac; Thomas E Shenk
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 7.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 8.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

9.  Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H.

Authors:  Aja H Davis; Natalya V Guseva; Brianne L Ball; Jonathan W Heusel
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.